These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1848677)

  • 81. The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.
    Cresto N; Gardier C; Gubinelli F; Gaillard MC; Liot G; West AB; Brouillet E
    Eur J Neurosci; 2019 Feb; 49(3):339-363. PubMed ID: 30269383
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Analysis of age-related changes in psychosine metabolism in the human brain.
    Marshall MS; Jakubauskas B; Bogue W; Stoskute M; Hauck Z; Rue E; Nichols M; DiAntonio LL; van Breemen RB; Kordower JH; Saavedra-Matiz CA; Bongarzone ER
    PLoS One; 2018; 13(2):e0193438. PubMed ID: 29481565
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.
    Braak H; Del Tredici K
    Cold Spring Harb Perspect Biol; 2016 Nov; 8(11):. PubMed ID: 27580631
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neurological disorders and therapeutics targeted to surmount the blood-brain barrier.
    Kanwar JR; Sriramoju B; Kanwar RK
    Int J Nanomedicine; 2012; 7():3259-78. PubMed ID: 22848160
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ogg1 null mice exhibit age-associated loss of the nigrostriatal pathway and increased sensitivity to MPTP.
    Cardozo-Pelaez F; Sanchez-Contreras M; Nevin AB
    Neurochem Int; 2012 Oct; 61(5):721-30. PubMed ID: 22743193
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The Lewy body in Parkinson's disease and related neurodegenerative disorders.
    Wakabayashi K; Tanji K; Odagiri S; Miki Y; Mori F; Takahashi H
    Mol Neurobiol; 2013 Apr; 47(2):495-508. PubMed ID: 22622968
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals.
    Kanazawa T; Adachi E; Orimo S; Nakamura A; Mizusawa H; Uchihara T
    Brain Pathol; 2012 Jan; 22(1):67-78. PubMed ID: 21672073
    [TBL] [Abstract][Full Text] [Related]  

  • 88. alpha-Synuclein and neuronal cell death.
    Cookson MR
    Mol Neurodegener; 2009 Feb; 4():9. PubMed ID: 19193223
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections.
    Kanazawa T; Uchihara T; Takahashi A; Nakamura A; Orimo S; Mizusawa H
    Brain Pathol; 2008 Jul; 18(3):415-22. PubMed ID: 18394008
    [TBL] [Abstract][Full Text] [Related]  

  • 90. LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.
    Alegre-Abarrategui J; Ansorge O; Esiri M; Wade-Martins R
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):272-83. PubMed ID: 17971075
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A specific clinical pattern of camptocormia in Parkinson's disease.
    Lepoutre AC; Devos D; Blanchard-Dauphin A; Pardessus V; Maurage CA; Ferriby D; Hurtevent JF; Cotten A; Destée A; Defebvre L
    J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1229-34. PubMed ID: 16735399
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
    Smith WW; Margolis RL; Li X; Troncoso JC; Lee MK; Dawson VL; Dawson TM; Iwatsubo T; Ross CA
    J Neurosci; 2005 Jun; 25(23):5544-52. PubMed ID: 15944382
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Impaired gastric myoelectrical activity in patients with Parkinson's disease and effect of levodopa treatment.
    Lu CL; Shan DE; Chen CY; Luo JC; Chang FY; Lee SD; Wu HC; Chen JD
    Dig Dis Sci; 2004 May; 49(5):744-9. PubMed ID: 15259493
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?
    Saunders-Pullman R
    Endocrine; 2003 Jun; 21(1):81-7. PubMed ID: 12777707
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
    Braak H; Braak E; Yilmazer D; de Vos RA; Jansen EN; Bohl J
    J Neural Transm (Vienna); 1996; 103(4):455-90. PubMed ID: 9617789
    [TBL] [Abstract][Full Text] [Related]  

  • 96. An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism.
    Hayashida K; Oyanagi S; Mizutani Y; Yokochi M
    Acta Neuropathol; 1993; 85(4):445-8. PubMed ID: 8480516
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Neuronal inclusions of Parkinson's disease.
    Gibb WR; Scott T; Lees AJ
    Mov Disord; 1991; 6(1):2-11. PubMed ID: 1848677
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies.
    Hill WD; Lee VM; Hurtig HI; Murray JM; Trojanowski JQ
    J Comp Neurol; 1991 Jul; 309(1):150-60. PubMed ID: 1716646
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies.
    Tiller-Borcich JK; Forno LS
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):526-35. PubMed ID: 2845001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.